Blood pressure drug recalled nationwide over fears it contains metal
A commonly used blood pressure pill sold nationwide has been urgently recalled over fears it may contain metal.
Breckenridge Pharmaceutical, Inc issued the recall notice Monday for its Propranolol Hydrochloride Extended-Release Capsules, a beta blocker that treats high blood pressure and other cardiovascular concerns.
The company said the 60mg white capsules, manufactured by Adare Pharma, could potentially contain pieces of metal that, if ingested, may cause ‘lacerations of soft tissues in the oral cavity, esophagus, stomach or intestine’.
No injuries or adverse side effects have been reported.
The affected pills, sold in 100-count bottles, were distributed across the country to wholesalers and pharmacies by Breckenridge Pharmaceutical between October 26 and November 4.
Recalled capsules had an expiration date of May 2029 and the lot number PK25110035. It’s unclear how many bottles were in each lot or exactly where they were distributed.
The company urged anyone who was prescribed the drug from the impacted lot to ‘immediately’ stop taking it and contact their doctor.
Additionally, consumers ‘should return any unused portion of the affected product to the pharmacy where it was obtained,’ the company said.
Blood pressure pills taken by up to 10 million Americans have been recalled because they may contain metal
Your browser does not support iframes.
The Food and Drug Administration (FDA) urged anyone who experiences adverse events related to the pills to contact their doctor and report the incident to the agency’s MedWatch Adverse Event Reporting program.
Propranolol, which is prescribed to about 10 million Americans, is a beta blocker, meaning it blocks the stress hormones epinephrine (adrenaline) and norepinephrine (noradrenaline) from binding to beta receptors on the cells.
This dampens the body’s ‘fight-or-flight response,’ putting less stress on the heart and lowering heart rate and blood pressure.
Propranolol is approved to treat high blood pressure, chest pain, heart rhythm disorders and hypertrophic subaortic stenosis, which causes a thickened heart muscle to restrict blood from the heart’s left ventricle to the aorta.
It’s also approved in the US for migraines and essential tremor by calming nerve and vascular responses.
It’s unclear how metal may have gotten into the capsules, though similar recalls have been linked to wear and tear on manufacturing equipment, contaminated raw materials or issues with packaging.
Lacerations in the esophagus can lead to trouble swallowing, bleeding and the leakage of saliva, food or stomach contents into surrounding neck or chest tissues, which may cause infection.
In the stomach or intestines, these injuries can cause food or stool to leak into the abdominal cavity, causing internal bleeding or life-threatening infections.
The event is the latest in a series of blood pressure pill recalls.
Pictured above is one of the recalled blood pressure capsules
Pictured above is the label of the recalled blood pressure capsules
Last month, New Jersey-based Teva Pharmaceuticals US and distributor Amerisource Health Services voluntarily recalled more than 580,000 bottles of various strengths of prazosin hydrochloride over fears they may contain compounds linked to cancer in animal studies.
Another recall from earlier this year of Chlorthalidone tablets was first issued due to ‘failed dissolution specifications.’
This means there is a problem with how the medication dissolves in the body, which could indicate the drug dissolves too slowly, too quickly or not fully.
A recent recall of Olmesartan Medoxomil, Amlodipine and Hydrochlorothiazide blood pressure tablets was also issued because they did not dissolve properly.